Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

PMID: 4394650Sep 26, 1970

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

British Medical Journal

D J Coltart, D G Shand

Abstract

Plasma propranolol levels associated with reductions in endogenous and exogenous cardiac beta-stimulation were determined in normal people. The levels associated with a given degree of blockade of exercise-induced tachycardia were about three times greater after intravenous administration than after oral administration. This shows that an active metabolite of propranolol is formed only after the drug is taken by mouth. The greatest reduction in the tachycardia of strenuous exercise was associated with plasma levels of 40 ng./ml. with oral administration and 100 ng./ml. with intravenously administered propranolol.The effect on isoprenaline-induced tachycardia following intravenously administered propranolol showed that the dose ratio for isoprenaline was about 30 with plasma levels of 100 ng./ml. and 10 with levels of 10-20 ng./ml. These plasma levels give 100% and 20-30% blockade of exercise-induced tachycardia. These findings suggest that some of the therapeutic effects of propranolol may be unrelated to beta-adrenergic blockade.

References

Effects of atropine on heart-rate in healthy man

Jul 1, 1967·Lancet·D A ChamberlainJ M Sneddon

Multicenter trial of propranolol in angina pectoris

Sep 1, 1966·The American Journal of Cardiology·R H GrantK Sinclair

Supervision of epileptic patients taking phenytoin

Jan 17, 1970·British Medical Journal·F B GibberdB L Hazleman

Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog

May 1, 1968·Circulation Research·L D Davis, J V Temte

Treatment of hypertension with propranolol

Jan 4, 1969·British Medical Journal·B N Prichard, P M Gillam

Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise

Aug 1, 1966·Circulation Research·B F RobinsonE Braunwald

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

Sep 1, 1965·The American Journal of Medicine·C A ChidseyA G MORROW

Citations

A comparison of intravenous pindolol and propranolol in normal man

May 1, 1972·The Journal of Clinical Pharmacology and New Drugs·D C HicksM Hills

A controlled evaluation of propranolol in chronic alcoholic patients presenting the symptomatology of anxiety and tension

Jan 1, 1973·The Journal of Clinical Pharmacology and New Drugs·D M GallantR Guerrero-Figueroa

Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients

Apr 1, 1976·Journal of Clinical Pharmacology·G M LondonP L Milliez

Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know?

Jun 1, 1996·Journal of Clinical Pharmacology·A Karim

Reversal of ethanol intoxications in humans: an assessment of the efficacy of propranolol

Dec 21, 1976·Psychopharmacology·R L AlkanaE P Noble

Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol

Jan 1, 1988·European Journal of Clinical Pharmacology·P H JoubertA Wellstein

Beta-blocking and electrophysiological effects of propafenone in volunteers

Jan 1, 1983·European Journal of Clinical Pharmacology·H Müller-PeltzerM Hollmann

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man

Jan 1, 1985·European Journal of Clinical Pharmacology·A WellsteinG G Belz

An investigation of the relationship between beta-adrenoceptor blockade and plasma practolol concentration in man

Jul 26, 1974·European Journal of Clinical Pharmacology·C R Kumana, C M Kaye

An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade

Aug 17, 1977·European Journal of Clinical Pharmacology·C R KumanaG E Marlin

Bioavailability of tolamolol

Feb 6, 1976·European Journal of Clinical Pharmacology·J K FaulknerS H Taylor

Relationship between plasma concentrations and pharmacological effects of labetalol

Jan 3, 1977·European Journal of Clinical Pharmacology·D A RichardsL E Martin

Pharmacokinetics--uses and abuses

Apr 4, 1975·European Journal of Clinical Pharmacology·P J Fell, M T Stevens

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity

Jun 15, 1976·European Journal of Clinical Pharmacology·P CollsteJ Ostman

Effects of (+)-propranolol on intracellular mechanisms of contraction in striated muscle of the rabbit

Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·J Y Su, D A Malencik

Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension

Nov 1, 1980·European Journal of Clinical Pharmacology·R T KredietL Offerhaus

Depressed tolbutamide-induced insulin response in subjects treated with propranolol

Aug 1, 1971·Diabetologia·F MassaraG M Molinatti

Oxidation phenotype and the metabolism and action of beta-blockers

Apr 1, 1985·Klinische Wochenschrift·M S Lennard

Insulin secretion during oral treatment with beta-adrenergic blocking agents in diabetics

Jan 1, 1976·Acta diabetologica latina

The use of propranolol in rapid sequence anaesthetic induction: optimal time interval for pretreatment

Nov 1, 1984·Canadian Anaesthetists' Society Journal·A M SafwatD C Bilton

Stereoselectivity in clinical pharmacokinetics and drug development

Apr 1, 1990·European Journal of Drug Metabolism and Pharmacokinetics·D B Campbell

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol

Nov 1, 1979·American Heart Journal·W Frishman, S Halprin

Noninvasive assessment of clinical response to oral propranolol therapy

May 1, 1975·The American Journal of Cardiology·W FrishmanT Killip

A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors

Nov 1, 1975·European Journal of Pharmacology·B N SinghR M Whitlock

Medical management of patients with angina pectoris

Jan 1, 1972·Progress in Cardiovascular Diseases·R E Goldstein, S E Epstein

Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization

Jan 1, 1992·Biomaterials·R SidenR J Levy

The polymorphic oxidation of beta-adrenoceptor antagonists

Jan 1, 1989·Pharmacology & Therapeutics·M S Lennard

Enantiomer-specific pharmacokinetics

Jan 1, 1990·Acta Pharmaceutica Nordica·G T Tucker

Pharmacologic approaches to psychogenic polydipsia: case reports

Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·R G KatholS C Olson

Mechanism of the antihypertensive effect of propranolol

Jan 1, 1979·General Pharmacology·B D Bhagat

Epinephrine-induced changes in serum potassium and cardiac repolarization and effects of pretreatment with propranolol and diltiazem

Jun 15, 1996·The American Journal of Cardiology·D DarbarD M Roden

Influence of hypothermia on the cardiac effects of propranolol observed in isolated rat atria

Jan 1, 1997·General Pharmacology·A L MelnikovD A Lathrop

Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation

Jun 1, 1983·Journal of the American College of Cardiology·E A RaederB Lown

Electrophysiologic actions of high plasma concentrations of propranolol in human subjects

Dec 1, 1983·Journal of the American College of Cardiology·H J DuffR L Woosley

Antiarrhythmic efficacy of propranolol: comparison of low and high serum concentrations

Oct 1, 1986·Journal of the American College of Cardiology·H J DuffD G Wyse

Hypertrophic obstructive cardiomyopathy in an infant--propranolol therapy for three years

Oct 7, 1971·The New England Journal of Medicine·D G ShandJ A Oates

Time required for complete recovery from chronic propranolol therapy

Sep 20, 1973·The New England Journal of Medicine·S L FaulknerD G Shand

Propranolol in the treatment of hypertension

Apr 22, 1976·The New England Journal of Medicine·O B Holland, N M Kaplan

Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension

Jul 8, 1976·The New England Journal of Medicine·J W HollifieldD G Shand

Variable plasma propranolol levels in thyrotoxicosis

Feb 15, 1979·The New England Journal of Medicine·S RubenfeldP O Kohler

Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy

Nov 4, 1982·The New England Journal of Medicine·J C ForfarA D Toft

Observations on the effect of β-adrenoceptor blocking drugs on glyceryl trinitrate tachycardia

Feb 1, 1974·British Journal of Clinical Pharmacology·J M EkueM J Walsh

The assessment of β-adrenoceptor blocking drugs in hyperthyroidism

Apr 1, 1974·British Journal of Clinical Pharmacology·S G CarruthersR G Shanks

Comparative trial of propranolol and practolol in hyperthyroidism

Oct 1, 1975·British Journal of Clinical Pharmacology·J K Nelson, D G McDevitt

An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man

Apr 1, 1975·British Journal of Clinical Pharmacology·G E MarlinP Turner

Intrinsic heart rate on exercise and the measurement of beta-adrenoceptor blockade

Dec 1, 1976·British Journal of Clinical Pharmacology·S G CarruthersD G McDevitt

Screening procedures in volunteers and patients

Feb 1, 1976·British Journal of Clinical Pharmacology·P J Tyrer

The assessment of beta-adrenoceptor blocking drugs in man

Aug 1, 1977·British Journal of Clinical Pharmacology·D G McDevitt

The effect of ageing on the hepatic clearance of propranolol

Jan 1, 1979·British Journal of Clinical Pharmacology·C M Castleden, C F George

Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia

Mar 1, 1979·British Journal of Clinical Pharmacology·G L JenningsP I Korner

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism

Aug 1, 1990·British Journal of Clinical Pharmacology·C Funck-BrentanoR L Woosley

The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women

Jan 1, 1996·British Journal of Clinical Pharmacology·L GullestadO M Sejersted

The vasodilator--beta-blocker interaction--some determinants of its clinical success

Aug 1, 1976·Australian and New Zealand Journal of Medicine·R Zacest

Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol

Sep 1, 1971·British Journal of Pharmacology·J D Fitzgerald, S R O'Donnell

Pharmacological analysis of established ventricular fibrillation

Jul 1, 1990·British Journal of Pharmacology·E J CarlisleA A Adgey

Plasma propranolol levels associated with suppression of ventricular ectopic beats

Feb 27, 1971·British Medical Journal·D J ColtartD G Shand

Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade

Jul 9, 1977·British Medical Journal·A E Raine, T G Pickering

Social drinking and drugs

Dec 5, 1981·British Medical Journal·M L Orme

The "top 50": a perspective on the BMJ drawn from the Science Citation Index

Oct 3, 1990·BMJ : British Medical Journal·B Dixon

New approach to assessment of cardioselectivity of beta-blocking drugs

Nov 23, 1974·British Medical Journal·C R KumanaD M Smith

Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses

May 1, 1973·British Heart Journal·M R Crouchman

Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery

Dec 1, 1975·British Heart Journal·D J ColtartD C Harrison

Baroreflex sensitivity in hypertension during beta-adrenergic blockade

Jan 1, 1979·British Heart Journal·R T Krediet, A J Dunning

Clinical electrophysiological effects of propranolol on normal sinus node function

Jun 1, 1979·British Heart Journal·M VasquezO S Narula

Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade

Sep 1, 1982·British Heart Journal·J C ForfarA D Toft

Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair

Aug 1, 1988·British Heart Journal·C BarazzoneB Friedli

beta-Adrenoreceptor antagonists in essential tremor

Oct 1, 1979·Journal of Neurology, Neurosurgery, and Psychiatry·D JeffersonC D Marsden

Relationship between plasma propranolol concentration and relief of essential tremor

Sep 1, 1979·Journal of Neurology, Neurosurgery, and Psychiatry·D JeffersonC D Marsden

The electrophysiological and contractile responses of hypertrophic cardiomyopathic myocardium

Dec 1, 1972·Postgraduate Medical Journal·D J Coltart

Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias

Jan 1, 1973·Postgraduate Medical Journal·E M PhillipsD G Ferriman

Plasma histamine concentration during propranolol induced bronchoconstriction

Dec 1, 1985·Thorax·P W IndC T Dollery

Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol

Apr 1, 1973·The Journal of Clinical Investigation·G BodemC A Chidsey

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

Dec 1, 1974·The Journal of Clinical Investigation·M A WeberJ M Gain

Nonadrenergic effects of isoproterenol in dogs with hypoxic pulmonary vasoconstriction. Possible role of prostaglandins

May 1, 1983·The Journal of Clinical Investigation·L J Rubin, J D Lazar

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade

Mar 1, 1990·The Journal of Clinical Investigation·K T MurrayR L Woosley

The effect of propranolol on exercise induced tachycardia is determined by plasma concentration and the density of adrenergic receptors on leukocytes

Jan 1, 1987·European Journal of Clinical Pharmacology·K TawaraC von Bahr

Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man

Sep 30, 1976·European Journal of Clinical Pharmacology·J F De PlaenT Reybrouck

Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs

Oct 5, 1984·The American Journal of Medicine·D T LowenthalK Conry

Beta Blocker Heart Attack Trial: design features

Dec 1, 1981·Controlled Clinical Trials

Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: a dilemma and a challenge

Jan 1, 1981·Pharmacology & Therapeutics·N S Baber

Central nervous control of blood pressure in relation to antihypertensive drug treatment

Jan 1, 1981·Pharmacology & Therapeutics·P I Korner, J A Angus

Antiarrhythmic action of adrenergic beta-receptor blocking agents

Jan 1, 1980·Pharmacology & Therapeutics·S D Seth

Antiarrhythmic agents and their use in therapy

Jan 1, 1980·Pharmacology & Therapeutics·L S Dreifus, J Morganroth

Spectrofluorometric determination of bufuralol in blood and urine

Aug 1, 1976·Journal of Pharmaceutical Sciences·J A de SilvaC V Puglisi

Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol

May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M S LennardH F Woods

Beta-adrenergic blockade does not influence the thermogenic response to a mixed meal in man

Aug 1, 1989·Clinical Physiology·A Thörne, J Wahren

Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death

Jan 1, 1982·Annals of the New York Academy of Sciences·D G ShandG S Wagner

Bioavailability assessment and pharmacologic response: impact of first-pass loss when both drug and metabolites are active

Dec 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·M Rowland

Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers

Dec 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·R L LalondeD M Mirvis

Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability

Aug 12, 1998·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A P MansurJ A Ramires

Fenoterol but not dobutamine increases erythropoietin production in humans

Jun 1, 1997·Clinical Pharmacology and Therapeutics·C H GleiterU Gundert-Remy

Propranolol and haemodynamic response in cirrhosis

Sep 1, 1991·Journal of Hepatology·Flemming BendtsenT I Sørensen

Altered hemoglobin-oxygen affinity with long-term propranolol therapy in patients with coronary artery disease

Jul 1, 1977·The American Journal of Cardiology·J D SchrumpfL S Cohen

Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease

Mar 1, 1975·Chest·L A NordstromF L Gobel

Cardiac and pulmonary effects of acebutolol

Jul 19, 1975·Lancet·C R KumanaJ Hamer

Importance of membrane stabilizing effect in massive overdose of propranolol: plasma level study in a fatal case

Jul 1, 1983·Human Toxicology·C Y HongB N Chiang

Influence of adiposity on tonic sympathetic support of resting metabolism in healthy adults

Oct 24, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C BellD R Seals

Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction

Sep 1, 1976·Circulation·H C StraussA G Wallace

Left ventricular wall motion response to intravenous propranolol

Jul 11, 1975·Circulation·S J ShubrooksJ W Harthorne

Dose response effectiveness of propranolol for the treatment of angina pectoris

Jun 1, 1975·Circulation·E L AldermanD C Harrison

Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise

Dec 1, 1973·Circulation·C R JorgensenH Taylor

Plasma and atrial propranolol after preoperative withdrawal

Dec 1, 1975·Circulation·A Romagnoli, A S Keats

Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol

Nov 1, 1974·Circulation·W H FrishmanT Killip

Efficacy of propranolol in the control of exercise-induced or augmented ventricular ectopic activity

Jan 1, 1978·Circulation·J V NixonW Shapiro

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

Apr 1, 1987·Circulation·L A SiddowayR L Woosley

Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs

Feb 1, 1990·Circulation Research·G W ParkerM L Entman

Suppression of chronic ventricular arrhythmias with propranolol

Oct 1, 1979·Circulation·R L WoosleyJ A Oates

LV filling in IHSS

Sep 1, 1978·Circulation·P Hanrath, D Mathey

The effect of propranolol on canine myocardial CPK distribution space and rate of disappearance

Aug 1, 1977·Circulation·J A Cairns, G A Klassen

Attenuation of exercise conditioning by beta-adrenergic blockade

Apr 1, 1982·Circulation·D L SableL D Horwitz

Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control

Mar 1, 1991·Psychophysiology·P GrossmanW Wieling

Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients

Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J VorobioffM Audano

Short-term effects of propranolol on portal venous pressure

Jan 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Garcia-TsaoJ L Alberts

Effect of beta-adrenoreceptor blockade on the renin response to acute natriuresis

Sep 1, 1980·Clinical and Experimental Pharmacology & Physiology·E VandongenA Tunney

Plasma propranolol concentration in patients with angina and acute myocardial infarction

Jul 1, 1976·Clinical and Experimental Pharmacology & Physiology·J D RutherfordR M Norris

The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man

Sep 1, 1976·Clinical and Experimental Pharmacology & Physiology·F M WilliamsR Dorrington

Effect of propranolol on the renin response to frusemide in man

Jun 1, 1980·Australian and New Zealand Journal of Medicine·R VandongenA Tunney

Cardiovascular responses in hyperthyroidism before and during beta-adrenoceptor blockade: evidence against adrenergic hypersensitivity

May 1, 1982·Clinical Endocrinology·J C ForfarA D Toft

Evidence for transient limitations in coronary blood flow during unstable angina pectoris: hemodynamic changes with spontaneous pain at rest versus exercise-induced ischemia following stabilization of angina

Oct 1, 1980·Clinical Cardiology·T C SmithermanJ V Nixon

Clinical assessment of beta blockade

May 1, 1988·Clinical Cardiology·M W WestonG H Lyman

Enantioselective analysis of propranolol and 4-hydroxypropranolol by CE with application to biotransformation studies employing endophytic fungi

Oct 31, 2009·Electrophoresis·Keyller Bastos BorgesPierina Sueli Bonato

Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450

Oct 15, 2005·Biotechnology and Bioengineering·Christopher R OteyFrances H Arnold

Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosis

Feb 28, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Aleksander KragFlemming Bendtsen

Pregnancy and cirrhosis

Aug 1, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jennifer TanSammy Saab

Assessment of beta-adrenergic blockade with propranolol in patients with cirrhosis

May 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E BercoffD Lebrec

Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites

Feb 28, 2013·International Journal of Molecular Sciences·Giovanna Di Nardo, Gianfranco Gilardi

Clinical pharmacology of propranolol

Jul 1, 1975·Circulation·A S Nies, D G Shand

Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol

Jul 1, 1981·British Journal of Clinical Pharmacology·H R GribbinA E Tattersfield

Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations

Jan 1, 1982·British Journal of Clinical Pharmacology·W H Aellig

Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man

May 1, 1987·British Journal of Clinical Pharmacology·R J UnwinW S Peart

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension

Jun 1, 1989·British Journal of Clinical Pharmacology·P CalèsJ P Pascal

Tonic sympathetic support of metabolic rate is attenuated with age, sedentary lifestyle, and female sex in healthy adults

Sep 11, 2001·The Journal of Clinical Endocrinology and Metabolism·C BellP P Jones

Anti-arrhythmic drugs

Jul 1, 1979·British Journal of Anaesthesia·I W CarsonR G Shanks

Microneedles for Transdermal Biosensing: Current Picture and Future Direction

Oct 7, 2015·Advanced Healthcare Materials·Letizia VentrelliGiuseppe Barillaro

The importance of stereochemistry in drug action and disposition

Oct 1, 1992·Journal of Clinical Pharmacology·J Caldwell

Absence of excess peripheral muscle fatigue during beta-adrenoceptor blockade

Apr 1, 1988·British Journal of Clinical Pharmacology·R G CooperR D Stark

Concentration-effect relationships with FM 24: a new long acting beta-adrenergic receptor antagonist

Jun 1, 1983·British Journal of Clinical Pharmacology·C T DolleryG Cuisinaud

Problems in assessing beta-adrenoceptor antagonism in man

Feb 1, 1975·British Journal of Clinical Pharmacology·C F George

Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol

Jan 1, 1975·Acta Pharmacologica Et Toxicologica·C G Regårdh

Cyclic AMP and plasma renin activity in renal vein blood after amitryptiline, theophylline, furosemide and beta adrenergic blocking substances (author's transl)

Nov 15, 1976·Klinische Wochenschrift·J ZehnerR Lemke

Duration of biological activity of pindolol in uremics (author's transl)

Aug 15, 1979·Klinische Wochenschrift·H M Herb, V Heinze

Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol

Jan 1, 1986·British Journal of Clinical Pharmacology·W H AelligJ Rosenthaler

The combination of nifedipine and propranolol in the management of patients with angina pectoris

Aug 1, 1981·British Journal of Clinical Pharmacology·A C TweddelI Hutton

A classification of antiarrhythmic actions reassessed after a decade of new drugs

Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams

Transient in oxygen uptake after step-increase of workload under beta-adrenoceptor blockade or vasodilation

Sep 1, 1983·British Journal of Clinical Pharmacology·F F Hendriks, J J Schipperheyn

Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man

Feb 1, 1975·British Journal of Clinical Pharmacology·M F Cuthbert, R F Collins

Increased plasma propranolol binding in myocardial infarction

Apr 1, 1980·British Journal of Clinical Pharmacology·P A RoutledgeD G Shand

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

Jun 1, 1984·British Journal of Clinical Pharmacology·M S LennardH F Woods

Stereoselective ring oxidation of propranolol in man

Nov 1, 1984·British Journal of Clinical Pharmacology·T WalleT E Gaffney

Antiarrhythmic drugs

Oct 1, 1980·Journal of Clinical Pharmacology·H W Moses, P N Yu

Pathophysiology and management of self-poisoning with beta-blockers

Jan 1, 1993·Journal of Toxicology. Clinical Toxicology·P TabouletC Bismuth

Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects

May 1, 1989·British Journal of Clinical Pharmacology·B FlouvatA Rossi

The effect of acute beta-adrenoceptor blockade on examination performance

Jun 1, 1985·British Journal of Clinical Pharmacology·P J DrewS J Evans

Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts

Feb 1, 1972·British Journal of Pharmacology·I M LedinghamJ R Parratt

Chiral bioequivalence: effect of absorption rate on racemic etodolac

Feb 24, 2001·Clinical Pharmacokinetics·J R BoniL Z Benet

Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits

Oct 1, 1980·British Journal of Pharmacology·A E Raine, E M Vaughan Williams

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade

Jun 15, 1976·European Journal of Clinical Pharmacology·P CollsteM D Rawlins

Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies

Aug 1, 1982·Journal of Clinical Pharmacology·C Pratt, E Lichstein

Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects

Sep 1, 1981·British Journal of Clinical Pharmacology·R VandongenA E Barden

Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans

Apr 5, 2001·American Journal of Physiology. Endocrinology and Metabolism·M B MonroeP Parker Jones

Assessment of "optimal" beta blockade in treating patients with angina pectoris

Jan 1, 1985·Acta Medica Scandinavica. Supplementum·U Thadani

Contrasts between pindolol and propranolol concentration-response relationships

Oct 1, 1985·British Journal of Clinical Pharmacology·S G CarruthersW H Aellig

Related Concepts

Adrenergic beta-Antagonists

Pulse Rate

Intravenous Injections

Novodrin

Rexigen

Tachycardia

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.